Schering-Plough - PDFSEARCH.IO - Document Search Engine

Schering-Plough
Results: 410

#	Item
141	MERCK IN PUERTO RICO / MSD IN THE CARIBBEAN 1 GRANTS, CHARITABLE CONTRIBUTIONS AND EQUIPMENT DONATIONS PROGRAM 2013 APPLICATION GUIDELINES Updated December 2012 I. Add to Reading List Source URL: www.msdcaribbean.com Language: English - Date: 2013-02-07 17:06:37 Readington New Jersey Schering-Plough Merck Manual of Diagnosis and Therapy Nonprofit organization Fundraising Puerto Rico Pharmaceutical industry Business Political geography Merck Dow Jones Industrial Average Merck & Co.
142	A Phase I Study of the Treatment of Recurrent Malignant Glioma with rQNestin34.5v.2 , a Genetically Engineered HSV-1 Virus, and immunomodulation with Cyclophosphamide Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-31 12:41:43 Health Amides Lactams Prodrugs Schering-Plough Temozolomide Nestin Glioma Cancer Medicine Brain tumor Biology
143	Microsoft Word[removed]CA Rabies Compendium Part III SW CF.docx Add to Reading List Source URL: www.cdph.ca.gov Language: English - Date: 2014-12-01 17:32:07 Zoonoses Rabies Merial Schering-Plough Rabies vaccine Cat Boehringer Ingelheim Biology Veterinary medicine Health
144	rw3.n" FOX ROTHSCHILD, LLP Midtown Building, 4th floor 1301 Atlantic Avenue Atlantic City, Ner.v Jersey 08401 Add to Reading List Source URL: www.judiciary.state.nj.us Language: English* - Date: 2014-02-24 16:21:16 Schering-Plough ATL T.I. Pharmaceutical industry Merck Dow Jones Industrial Average Merck & Co. Readington New Jersey
145	STN: BL[removed]– HSTCL PAS April 14, 2009 REMICADE® (infliximab) Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-06-07 20:41:28 Monoclonal antibodies Immunosuppressants Centocor Infliximab Schering-Plough Autoimmune diseases Rheumatoid arthritis TNF inhibitor Placebo Medicine Biology Pharmacology
146	Preclinical Models Repository to Support Cancer Discovery & Therapeutics Development NCI Pharma Add to Reading List Source URL: deainfo.nci.nih.gov Language: English - Date: 2013-10-29 07:27:53 Prodrugs Schering-Plough Temozolomide Carboplatin Chemistry Amides Lactams
147	Recent Developments in the Psychopharmacology of Depression Maurizio Fava, MD Executive Vice Chair, MGH Department of Psychiatry Executive Director, MGH Clinical Trials Network and Institute (CTNI) Director, MGH Depressi Add to Reading List Source URL: www.adaa.org Language: English - Date: 2014-06-04 13:01:39 Pharmaceutical industry in Bangladesh Novartis Pharmaceutical industry in India AstraZeneca Vion Pharmaceuticals Inc. Pharmaceutical drug Schering-Plough Pharmacology Pharmaceutical sciences Pharmaceutical industry
148	Desloratadine or Clarinex® Submitted by Dan Anderson - Los Angeles County Dept. of Coroner New orally administered antihistamine that is generally known as the main metabolite of loratadine or Claratin®. Desloratadine Add to Reading List Source URL: www.cal-tox.org Language: English - Date: 2010-09-16 16:37:10 Organochlorides Schering-Plough Desloratadine Loratadine Histamine antagonist Carbinoxamine Paroxetine Oxycodone Fentanyl Chemistry Organic chemistry Piperidines
149	Endocrinologic and Metabolic Drugs Advisory Committee VYTORIN / ZETIA NDAs[removed]and[removed]James P. Smith, MD, MS Division of Metabolism and Endocrinology Products Add to Reading List Source URL: www.fda.gov Language: English Organic chemistry Schering-Plough Ezetimibe Simvastatin Statin Hypercholesterolemia Low-density lipoprotein Familial hypercholesterolemia HMG-CoA reductase Chemistry Merck Medicine
150	Contact: Dr. Raymond Woosley President & CEO, The Critical Path Institute[removed]FOR IMMEDIATE RELEASE November 15, 2006 Add to Reading List Source URL: c-path.org Language: English - Date: 2014-02-20 17:49:57 Pharmaceutical industry Critical Path Institute Drug discovery Toxicogenomics Food and Drug Administration Novartis Schering-Plough Consortium Toxicology Pharmaceutical sciences Pharmacology Clinical research

UPDATE